SCHEMBL3484264

SCHEMBL3484264

O=C(O)c1ccc(CCC(C=Cc2ccccc2OCCCCc2ccccc2)Cc2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 2/20 0.48
PTGER4 P35408 2/20 0.48
PTGER3 P43115 2/20 0.48
PTGER2 P43116 2/20 0.48
PDE4A P27815 2/20 0.47
PDE4B Q07343 2/20 0.47
PDE4C Q08493 2/20 0.47
PDE4D Q08499 2/20 0.47
PLA2G4B P0C869 3/20 0.46
KMT2A Q03164 3/20 0.43
PPARG P37231 2/20 0.43
KDM4E B2RXH2 1/20 0.43
PSMD14 O00487 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
FFAR1 O14842 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3484259 1.00 PTGER1 (0.48) PTGER1PTGER4PTGER3PTGER2PDE4A
SCHEMBL3484738 0.99 PLA2G4B (0.47) PTGER1PTGER4PTGER3PTGER2PDE4A
SCHEMBL3484740 0.99 PLA2G4B (0.47) PTGER1PTGER4PTGER3PTGER2PDE4A
SCHEMBL3485010 0.99 PLA2G4B (0.47) PTGER1PTGER4PTGER3PTGER2PDE4A
SCHEMBL3485012 0.99 PLA2G4B (0.47) PTGER1PTGER4PTGER3PTGER2PDE4A
SCHEMBL3485351 0.97 PTGER1 (0.49) PTGER1PTGER4PTGER3PTGER2PDE4A
SCHEMBL3485347 0.97 PTGER1 (0.49) PTGER1PTGER4PTGER3PTGER2PDE4A
SCHEMBL8243984 0.95 PDE4A (0.45) PTGER1PTGER4PTGER3PTGER2PDE4A
SCHEMBL8245132 0.94 KMT2A (0.44) PTGER1PTGER4PTGER3PTGER2PDE4A
SCHEMBL3484553 0.92 RARB (0.43) PTGER1PTGER4PTGER3PTGER2PLA2G4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609727-B2 Dicarboxylic acid derivatives and their use BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-12-17 US disclosed
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029772-A1 Dicarboxylic Acid Derivatives and their Use PC, SLC25A1, GOT2 PTGER1 2299/4885PTGER4 2636/4885PTGER3 2113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.